ArticleJournal of cardiovascular translational research2016

Lysophospholipid Receptors, as Novel Conditional Danger Receptors and Homeostatic Receptors Modulate Inflammation-Novel Paradigm and Therapeutic Potential.

Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.